Minimize Adverse Events, Maximize Adherence With PEG, Reduce Adverse Events with PEG, PEG: Polyethylene glycol., Muout, Pediatrics, Pediatric functional constipation, Paediatrician.
Many children with chronic constipation require long-term laxative therapy to manage their condition effectively. Despite their safety, these laxatives can be associated with adverse effects which significantly impact treatment adherence.2
Reasons for Non-Adherence:
Medication refusal
among children taking
laxatives for 12 months.2
40.2% of cases cited
drug adverse effects
as a reason.3
PEG vs. Lactulose:
As a result of its tolerability, PEG led to a higher adherence rate compared to other laxatives.3,4
Would you consider PEG as a more viable option than lactulose for improving adherence in long-term laxative therapy for children?
Abbreviation ▼
PEG: Polyethylene glycol.
References ▼
1.Pashankar DS, et. al. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med. 2003;157(7):661–664. 2. Alper A, Pashankar DS. Polyethylene glycol: A game-changer laxative for children. J Pediatr Gastroenterol Nutr. 2013;57(2):134–140. 3. Steiner SA, Torres MR, Penna FJ, et al. Chronic functional constipation in children: Adherence and factors associated with drug treatment. J Pediatr Gastroenterol Nutr. 2014;58(5):598–602. 4. Mathew JL. Polyethylene glycol vs. lactulose in infants and children with functional constipation: Evidence-based medicine viewpoint. Indian Pediatr. 2019;56(5):415–418.
LMRC Code: GGI-CO-A1-AQS-300021153-ELC-H24-0883
For the use of a Registered Medical Practitioner, Hospital or Laboratory only.
Disclaimer
The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.
All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.
